DexComvsThermo Fisher Scientific

DXCM and TMO stock compared: price, dividend, valuation and results, from SEC filings.

DXCM

DexCom, Inc.

$81.61

Value $31.4B

-2.06%
DXCM's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

DexCom (DXCM) has a market value of $31.4B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, DXCM moved +40.6% and TMO +19.9%. The P/E is 31.7 for DXCM and 36.3 for TMO. Dividend yield: DXCM none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    DXCM$31.4B

    TMO$257B

    TMO is 8.2 times DXCM

  • Revenue, 12 months

    DXCM$5.1B

    TMO$47.4B

    TMO is 9.3 times DXCM

  • Net income, 12 months

    DXCM$991M

    TMO$7.1B

    TMO is 7.1 times DXCM

  • Operating margin

    DXCM24.0%

    TMO17.9%

    6.1 points apart

  • ROIC

    DXCM19.5%

    TMO8.2%

    11.3 points apart

  • P/E

    DXCM31.7

    TMO36.3

    TMO is 1.1 times DXCM

  • Dividend yield

    DXCM0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    DXCM-49.1%

    TMO+10.9%

    60.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

DXCM-49.1%

TMO+10.9%

507510020222023202420252026
Returns by period
PeriodDXCMWith dividendsTMOWith dividends
1 year since November 14, 2025+40.6%Price +40.6%+19.9%Price +19.5%
3 years since November 16, 2023-22.1%-8.0% a yearPrice -22.1%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-49.1%-12.7% a yearPrice -49.1%+10.9%+2.1% a yearPrice +9.3%
10 years since November 16, 2016+358.0%+16.4% a yearPrice +358.0%+375.7%+16.9% a yearPrice +362.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

DXCMDexComTMOThermo Fisher Scientific

Valuation

DXCMTMO
Valuation
Price$81.61$691.33
Market value$31.4B$257B
Enterprise value (EV)$31.0B$292B
P/E31.736.3
P/E, 5-year median54.832.7
P/B12.44.7
EV/EBIT25.434.5
Free cash flow yield3.5%3.0%

Results and growth

DXCMTMO
Results and growth
Revenue, 12 months$5.1B$47.4B
Net income, 12 months$991M$7.1B
Free cash flow, 12 months$1.1B$7.6B
Earnings per share, 12 months$2.54$18.96
Revenue growth, year on year15.6%3.9%
Revenue growth a year, past+19.3%over 5 years+6.7%over 5 years
EPS growth a year, past+44.4%over 5 years+2.1%over 5 years

Margins and returns on capital

DXCMTMO
Margins and returns on capital
Gross margin63.4%–
Operating margin24.0%17.9%
Net margin19.4%14.9%
ROIC19.5%8.2%
ROE36.5%13.4%

Balance sheet

DXCMTMO
Balance sheet
Cash$1.7B$6.1B
Total debt$1.4B$41.4B
Net debt / EBITDA-0.33.7
Interest cover128.8×5.5×

Dividends and buybacks

DXCMTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield1.6%1.2%
Shareholder yield1.6%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: DXCM or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, DexCom or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 8.2 times DexCom ($31.4B), at today's prices.

How did DXCM and TMO stock do over the last 10 years?

Since November 16, 2016, DXCM's price moved +358.0% and TMO's +362.5%. With dividends: DXCM +358.0% (+16.4% a year), TMO +375.7% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, DXCM or TMO?

The dividend yield at today's price is none for DexCom and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of DXCM and TMO?

At today's price, the P/E is 31.7 for DXCM and 36.3 for TMO. The median of the last five years was 54.8 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, DexCom or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 19.4% for DexCom and 14.9% for Thermo Fisher Scientific, and the operating margin 24.0% and 17.9%. Revenue was $5.1B and $47.4B.

Which is the better investment, DexCom or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.